Literature DB >> 20813145

Aberrant regulation of alternative pre-mRNA splicing in schizophrenia.

Tomomi Morikawa1, Takayuki Manabe.   

Abstract

Alternative pre-mRNA splicing plays a key role in the control of gene expression in both neurons and glial cells, and failure or dysregulation of these splicing events can cause developmental abnormalities and lead to the development of pathology. Schizophrenia is a common mental disorder that presents as a complex condition. Many factors, of genetic, epigenetic and environmental etiology, such as developmental abnormalities in myelination, synapses and neurotransmission, have been implicated in this disorder. Intriguingly, aberrant alternative splicing of genes related to neurodevelopment and neural function has been detected in schizophrenia and related disorders. In this review, we discuss the aberrant splicing of specific genes for each candidate cause of schizophrenia. Finally, we discuss the only example that has been researched in detail, from the cause to clarification of the mechanism, in ongoing studies into the associations between brain disorders and abnormal splicing.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813145     DOI: 10.1016/j.neuint.2010.08.012

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  16 in total

Review 1.  Characters, functions and clinical perspectives of long non-coding RNAs.

Authors:  Ruifang Wu; Yuwen Su; Haijing Wu; Yong Dai; Ming Zhao; Qianjin Lu
Journal:  Mol Genet Genomics       Date:  2016-02-17       Impact factor: 3.291

2.  Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.

Authors:  Y Kunii; T M Hyde; T Ye; C Li; B Kolachana; D Dickinson; D R Weinberger; J E Kleinman; B K Lipska
Journal:  Mol Psychiatry       Date:  2013-01-08       Impact factor: 15.992

3.  The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing.

Authors:  G Barry; J A Briggs; D P Vanichkina; E M Poth; N J Beveridge; V S Ratnu; S P Nayler; K Nones; J Hu; T W Bredy; S Nakagawa; F Rigo; R J Taft; M J Cairns; S Blackshaw; E J Wolvetang; J S Mattick
Journal:  Mol Psychiatry       Date:  2013-04-30       Impact factor: 15.992

Review 4.  The Long Non-Coding RNA GOMAFU in Schizophrenia: Function, Disease Risk, and Beyond.

Authors:  Paul M Zakutansky; Yue Feng
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

5.  Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.

Authors:  S S Kaalund; E N Newburn; T Ye; R Tao; C Li; A Deep-Soboslay; M M Herman; T M Hyde; D R Weinberger; B K Lipska; J E Kleinman
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

6.  A screen of 1,049 schizophrenia and 30 Alzheimer's-associated variants for regulatory potential.

Authors:  Leslie Myint; Ruihua Wang; Leandros Boukas; Kasper D Hansen; Loyal A Goff; Dimitrios Avramopoulos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-09-10       Impact factor: 3.568

7.  Nuclear ARVCF protein binds splicing factors and contributes to the regulation of alternative splicing.

Authors:  Ulrike Rappe; Tanja Schlechter; Moritz Aschoff; Agnes Hotz-Wagenblatt; Ilse Hofmann
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

8.  Emerging Roles of Alternative Pre-mRNA Splicing Regulation in Neuronal Development and Function.

Authors:  Adam D Norris; John A Calarco
Journal:  Front Neurosci       Date:  2012-08-21       Impact factor: 4.677

Review 9.  Noncoding RNA crosstalk in brain health and diseases.

Authors:  Suresh L Mehta; Anil K Chokkalla; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2021-07-16       Impact factor: 4.297

Review 10.  From Junk to Function: LncRNAs in CNS Health and Disease.

Authors:  Rafaela Policarpo; Annerieke Sierksma; Bart De Strooper; Constantin d'Ydewalle
Journal:  Front Mol Neurosci       Date:  2021-07-19       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.